3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is growing attracting researcher scrutiny due to sparse data suggesting different biological properties. Current research suggest that 3-HPC may possess distinct responses on the nervous structure, potentially influencing to some of the unanticipated symptoms linked with PCP use.